Podjęzykowa immunoterapia alergenowa – stanowisko Sekcji Immunoterapii Polskiego Towarzystwa Alergologicznego
Alergologia Polska - Polish Journal of Allergology · 2014
DOI: 10.1016/j.alergo.2014.03.002 ↗Kurz gefasst
Fachartikel in der Zeitschrift Alergologia Polska - Polish Journal of Allergology, 2014. Verfasst von Marek Jutel und 9 weiteren Autor:innen. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 90 Literaturangaben.
Abstract (Originalsprache)
SLIT (sublingual immunotherapy) is a therapeutic method aiming at producing allergen-specific tolerance of the immune system to a gradually increasing dose of an allergen that is administered sublingually. SLIT initiates similar immune mechanisms as does subcutaneous immunotherapy (SCIT). The aim of the study at this position is to update the current knowledge on sublingual immunotherapy. Randomized double-blind, placebo-controlled (RDBPC) studies that compared both immunotherapy forms point to an advantage of SCIT over SLIT in decreasing symptoms of asthma and allergic rhinitis, a comparable effect of both the methods on immune parameters (sIgE, IL-10) and upper respiratory tract inflammations and an advantage of SCIT over SLIT with respect to lower respiratory tract inflammations as based on provocation tests. At present, there are no grounds for recommending SLIT in food allergy. In view of the high safety profile and absence of anxiety-provoking infections, SLIT may be the method that is more often selected in children as compared to adults. On the other hand, immune mechanisms and results of clinical trials provide an argument for preferential employment of SCIT in adults. It should be borne in mind, however, that SLIT is effective if a good quality vaccine with a high allergen dose, is employed for at least three years. National and international reports indicate the necessity of conducting further clinical trials, especially including a direct comparison between SCIT and SLIT with respect to effectiveness and safety.
Zitieren
APA
Jutel, M., Bartkowiak-Emeryk, M., Bręborowicz, A., Cichocka-Jarosz, E., Emeryk, A., Gawlik, R., Gonerko, P., Rogala, B., Nowak-Węgrzyn, A., & Samoliński (2014). Podjęzykowa immunoterapia alergenowa – stanowisko Sekcji Immunoterapii Polskiego Towarzystwa Alergologicznego. Alergologia Polska - Polish Journal of Allergology. https://doi.org/10.1016/j.alergo.2014.03.002
Vancouver
Jutel M, Bartkowiak-Emeryk M, Bręborowicz A, Cichocka-Jarosz E, Emeryk A, Gawlik R, et al. Podjęzykowa immunoterapia alergenowa – stanowisko Sekcji Immunoterapii Polskiego Towarzystwa Alergologicznego. Alergologia Polska - Polish Journal of Allergology. 2014. doi:10.1016/j.alergo.2014.03.002
BibTeX
@article{Jutel2014,
author = {Jutel, Marek and Bartkowiak-Emeryk, Małgorzata and Bręborowicz, Anna and Cichocka-Jarosz, Ewa and Emeryk, Andrzej and Gawlik, Radosław and Gonerko, Paweł and Rogala, Barbara and Nowak-Węgrzyn, Anna and Samoliński},
title = {Podjęzykowa immunoterapia alergenowa – stanowisko Sekcji Immunoterapii Polskiego Towarzystwa Alergologicznego},
journal = {Alergologia Polska - Polish Journal of Allergology},
year = {2014},
doi = {10.1016/j.alergo.2014.03.002}
}
EUVIMED